Table 1. Primers information and RT-qPCR conditions used in the trial.
Gene1 | NCBI accession number | Oligo sequence (5′→3′) | Amplicon length | Annealing T | |
ATP4A | M22724 | Forward Reverse | GCATATGAGAAGGCCGAGAG TGGCCGTGAAGTAGTCAGTG | 151 pb | 57°C |
GAST | NM_001004036 | Forward Reverse | GACTCTGCGCCTATGTCCTG GCTCTTTGCCCCTGTTGG | 133 bp | 60°C |
GHRL | NM213807 | Forward Reverse | GAACAGAGGTGGCTGGTCTC ACAGGGGAGACAAGGAAAGG | 202 pb | 62°C |
PIGR | NM_214159.1 | Forward Reverse | AGCCAACCTCACCAACTTCC CTGCTAATGCCCAGACCAC | 105 bp | 62°C |
HMBS | DQ845174 | Forward Reverse | AGGATGGGCAACTCTACCTG GATGGTGGCCTGCATAGTCT | 83 bp | 62°C |
RPL4 | DQ845176 | Forward Reverse | CAAGAGTAACTACAACCTTC GAACTCTACGATGAATCTTC | 122 bp | 60°C |
ATP4A, H+/K+ Atpase α; GAST, gastrin; GHRL, ghrelin/obestatin prepropeptide; PIGR, polymeric immunoglobulin receptor; HMBS, hydroxymethylbilane synthase; RPL4, ribosomal protein L4.